BCYC•benzinga•
Bicycle Therapeutics Q4 2024 GAAP EPS $(0.75) Beats $(0.87) Estimate, Cash And Cash Equivalents Of $879.5M As Of December 31, 2024, Expected To Provide Financial Runway Into 2H 2027
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 25, 2025 by benzinga